A carregar...
Brain proteomic changes by histone deacetylase inhibition after traumatic brain injury
BACKGROUND: Traumatic brain injury (TBI) is a leading cause of morbidity and mortality. There are currently no cytoprotective treatments for TBI. There is growing evidence that the histone deacetylase inhibitor valproic acid (VPA) may be beneficial in the treatment of TBI associated with hemorrhagic...
Na minha lista:
| Publicado no: | Trauma Surg Acute Care Open |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMJ Publishing Group
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7993337/ https://ncbi.nlm.nih.gov/pubmed/33880414 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/tsaco-2021-000682 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|